|
Volumn 15, Issue 5, 2000, Pages 257-261
|
Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: A placebo-controlled study
a a a a a |
Author keywords
Fluvoxamine; Negative symptoms; Positive symptoms; Schizophrenia; Serotonin; SSRI augmentation; Treatment resistance
|
Indexed keywords
ANTIPARKINSON AGENT;
BENZODIAZEPINE DERIVATIVE;
BIPERIDEN;
CARBAMAZEPINE;
CHLORPROMAZINE;
FLUPENTIXOL;
FLUVOXAMINE;
HALOPERIDOL;
LITHIUM;
PENFLURIDOL;
PERPHENAZINE;
SEROTONIN UPTAKE INHIBITOR;
TRIHEXYPHENIDYL;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
ISRAEL;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
SYMPTOM;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 0033845691
PISSN: 02681315
EISSN: None
Source Type: Journal
DOI: 10.1097/00004850-200015050-00002 Document Type: Article |
Times cited : (84)
|
References (22)
|